All entries for: Korro Bio, Inc

March 12, 2026

Korro Bio, Inc

Neutral Outlook

Cambridge, MA
51-200 employees

the overall effects of the IRA on our business and the healthcare industry in general is not yet known.

Disease Area: Metabolic Diseases, Neurological Diseases, Rare Diseases
Drug Type: Biologic
Scroll to Top